Cover Image

Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression

OBJECTIVE: To evaluate long-term safety and efficacy of esketamine nasal spray plus a new oral antidepressant (OAD) in patients with treatment-resistant depression (TRD). METHODS: This phase 3, open-label, multicenter, long-term (up to 1 year) study was conducted between October 2015 and October 201...

Full description

Saved in:
Bibliographic Details
Main Authors: Wajs, Ewa, Aluisio, Leah, Holder, Richard, Daly, Ella J., Lane, Rosanne, Lim, Pilar, George, Joyce E., Morrison, Randall L., Sanacora, Gerard, Young, Allan H., Kasper, Siegfried, Sulaiman, Ahmad Hatim, Li, Cheng Ta, Paik, Jong Woo, Manji, Husseini, Hough, David, Grunfeld, Jennifer, Jeon, Hong Jin, Wilkinson, Samuel T., Drevets, Wayne C., Singh, Jaskaran B.
Format: Article
Published: Physicians Postgraduate Press 2020
Subjects:
R Medicine
Online Access:http://eprints.um.edu.my/24773/
https://doi.org/10.4088/JCP.19m12891
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://eprints.um.edu.my/24773/
https://doi.org/10.4088/JCP.19m12891

Similar Items